Cel-Sci Corporation (CVM): Price and Financial Metrics
Today's Latest Price: $12.28 USD
Nov 24 8:00pm Add CVM to Watchlist Sign Up
CVM Stock Summary Cel Sci Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.75% of US listed stocks. CVM's went public 29.14 years ago, making it older than 83% of listed US stocks we're tracking. CVM's price/sales ratio is 710.32; that's higher than the P/S ratio of 99.1% of US stocks. Stocks that are quantitatively similar to CVM, based on their financial statements, market capitalization, and price volatility, are ORGS, AMBA, WATT, IMAB, and IPHI. CVM's SEC filings can be seen here. And to visit Cel Sci Corp's official web site, go to cel-sci.com.
CVM Price/Volume Stats
CVM Latest News Stream
All News Types
Loading, please wait...
Latest CVM News From Around the Web
Below are the latest news stories about Cel Sci Corp that investors may wish to consider to help them evaluate CVM as an investment opportunity.
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation issues letter to shareholders.
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to Present at H.C. Wainwright 22nd Annual Global Investment Conference
CEL-SCI ([[CVM]] +4.7%) bucks the broad market's softness, albeit on below-average volume, after reporting encouraging results from animal studies on its LEAPS COVID-19 conjugates that, it says, showed faster and "much higher than expected" antibody responses against a non-mutating region of SARS-CoV-2 after only one injection. IgG antibody response was...
CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment.
We can readily understand why investors are attracted to unprofitable companies. Indeed, CEL-SCI (NYSEMKT:CVM) stock...
Read More 'CVM' Stories Here
CVM Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.9344 seconds.